QUCY earnings: next report 2026-09-09, real EPS beat/miss history, P/E -2.65. Updated 2026-07-23.
Quantum Cyber (QUCY) Research Hub
Quantum Cyber (QUCY) trades on NASDAQ, DE in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 1.34 USD (-3.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.65, market cap 0.01B. This hub links to the full technical, earnings and options research available for QUCY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, DE |
| Last close | 1.34 USD (-3.60%) |
| 52-week range | 1.03 USD – 2.36 USD |
| Trend regime | Range |
| 14-day RSI | 44.3 (Bearish) |
| Trailing P/E | -2.65 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-09 |
Available research for QUCY
Covered Call on QUCY: how it works, illustrative setup around the real 1.34 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on QUCY: how it works, illustrative setup around the real 1.34 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on QUCY: how it works, illustrative setup around the real 1.34 USD price, max profit/loss, breakeven and when to use it. Educational.
QUCY technical analysis: range, last 1.34 USD, RSI 44.3, 52w range 1.03 USD–2.36 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is QUCY in?
Quantum Cyber (QUCY) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, DE.
Is QUCY in an uptrend or downtrend?
As of 2026-09-11, QUCY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is QUCY's trailing P/E ratio?
QUCY's trailing P/E is -2.65, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does QUCY next report earnings?
QUCY is next scheduled to report earnings on 2026-09-09, with a consensus EPS estimate of -38.8 USD.